 | • レポートコード：MRC2Q12-03245 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、トラネキサム酸APIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にトラネキサム酸APIのグローバル市場のxxx％を占める「0.98」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 トラネキサム酸APIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのトラネキサム酸API市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 トラネキサム酸APIのグローバル主要プレイヤーには、Hunan Huateng Pharmaceutical、Xian Libang Pharmaceutical、Hangzhou Longshine Bio-Tech、Inabata France S.A.S、Transo-Pharm Handels GmbH、Malladi Drugs & Pharmaceuticals、Rochem International、Metrochem API、Ami Lifesciences、Supriya Lifescience、ALP Pharm、Kyowa Pharma Chemical、Pfizer Inc、Shilpa Medicare、Solara Active Pharma Sciences、Vitalpharmsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 トラネキサム酸API市場は、種類と用途によって区分されます。世界のトラネキサム酸API市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.98、0.99、その他 【用途別セグメント】 錠剤、カプセル剤、注射液、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - トラネキサム酸API製品概要 - 種類別市場（0.98、0.99、その他） - 用途別市場（錠剤、カプセル剤、注射液、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のトラネキサム酸API販売量予測2017-2028 - 世界のトラネキサム酸API売上予測2017-2028 - トラネキサム酸APIの地域別販売量 - トラネキサム酸APIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別トラネキサム酸API販売量 - 主要メーカー別トラネキサム酸API売上 - 主要メーカー別トラネキサム酸API価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0.98、0.99、その他） - トラネキサム酸APIの種類別販売量 - トラネキサム酸APIの種類別売上 - トラネキサム酸APIの種類別価格 ・用途別市場規模（錠剤、カプセル剤、注射液、その他） - トラネキサム酸APIの用途別販売量 - トラネキサム酸APIの用途別売上 - トラネキサム酸APIの用途別価格 ・北米市場 - 北米のトラネキサム酸API市場規模（種類別、用途別） - 主要国別のトラネキサム酸API市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのトラネキサム酸API市場規模（種類別、用途別） - 主要国別のトラネキサム酸API市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のトラネキサム酸API市場規模（種類別、用途別） - 主要国別のトラネキサム酸API市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のトラネキサム酸API市場規模（種類別、用途別） - 主要国別のトラネキサム酸API市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのトラネキサム酸API市場規模（種類別、用途別） - 主要国別のトラネキサム酸API市場規模（トルコ、サウジアラビア） ・企業情報 Hunan Huateng Pharmaceutical、Xian Libang Pharmaceutical、Hangzhou Longshine Bio-Tech、Inabata France S.A.S、Transo-Pharm Handels GmbH、Malladi Drugs & Pharmaceuticals、Rochem International、Metrochem API、Ami Lifesciences、Supriya Lifescience、ALP Pharm、Kyowa Pharma Chemical、Pfizer Inc、Shilpa Medicare、Solara Active Pharma Sciences、Vitalpharms ・産業チェーン及び販売チャネル分析 - トラネキサム酸APIの産業チェーン分析 - トラネキサム酸APIの原材料 - トラネキサム酸APIの生産プロセス - トラネキサム酸APIの販売及びマーケティング - トラネキサム酸APIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - トラネキサム酸APIの産業動向 - トラネキサム酸APIのマーケットドライバー - トラネキサム酸APIの課題 - トラネキサム酸APIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Tranexamic Acid API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Tranexamic Acid API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Tranexamic Acid API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Tranexamic Acid API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Tranexamic Acid API include Hunan Huateng Pharmaceutical, Xian Libang Pharmaceutical, Hangzhou Longshine Bio-Tech, Inabata France S.A.S, Transo-Pharm Handels GmbH, Malladi Drugs & Pharmaceuticals, Rochem International, Metrochem API and Ami Lifesciences, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Tranexamic Acid API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Tranexamic Acid API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Tranexamic Acid API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Tranexamic Acid API market. Further, it explains the major drivers and regional dynamics of the global Tranexamic Acid API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hunan Huateng Pharmaceutical
Xian Libang Pharmaceutical
Hangzhou Longshine Bio-Tech
Inabata France S.A.S
Transo-Pharm Handels GmbH
Malladi Drugs & Pharmaceuticals
Rochem International
Metrochem API
Ami Lifesciences
Supriya Lifescience
ALP Pharm
Kyowa Pharma Chemical
Pfizer Inc
Shilpa Medicare
Solara Active Pharma Sciences
Vitalpharms
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Tranexamic Acid API Segment by Purity
0.98
0.99
Others
Tranexamic Acid API Segment by Application
Tablets
Capsules
Injection
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Tranexamic Acid API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tranexamic Acid API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Tranexamic Acid API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Tranexamic Acid API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Tranexamic Acid API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tranexamic Acid API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Tranexamic Acid API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Tranexamic Acid API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hunan Huateng Pharmaceutical, Xian Libang Pharmaceutical, Hangzhou Longshine Bio-Tech, Inabata France S.A.S, Transo-Pharm Handels GmbH, Malladi Drugs & Pharmaceuticals, Rochem International, Metrochem API and Ami Lifesciences, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Tranexamic Acid API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Tranexamic Acid API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Tranexamic Acid API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tranexamic Acid API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Tranexamic Acid API Product Introduction
1.2 Market by Purity
1.2.1 Global Tranexamic Acid API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tranexamic Acid API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Injection
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Tranexamic Acid API Production
2.1 Global Tranexamic Acid API Production Capacity (2017-2028)
2.2 Global Tranexamic Acid API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Tranexamic Acid API Production by Region
2.3.1 Global Tranexamic Acid API Historic Production by Region (2017-2022)
2.3.2 Global Tranexamic Acid API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Tranexamic Acid API Sales in Volume & Value Estimates and Forecasts
3.1 Global Tranexamic Acid API Sales Estimates and Forecasts 2017-2028
3.2 Global Tranexamic Acid API Revenue Estimates and Forecasts 2017-2028
3.3 Global Tranexamic Acid API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Tranexamic Acid API Sales by Region
3.4.1 Global Tranexamic Acid API Sales by Region (2017-2022)
3.4.2 Global Sales Tranexamic Acid API by Region (2023-2028)
3.5 Global Tranexamic Acid API Revenue by Region
3.5.1 Global Tranexamic Acid API Revenue by Region (2017-2022)
3.5.2 Global Tranexamic Acid API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Tranexamic Acid API Production Capacity by Manufacturers
4.2 Global Tranexamic Acid API Sales by Manufacturers
4.2.1 Global Tranexamic Acid API Sales by Manufacturers (2017-2022)
4.2.2 Global Tranexamic Acid API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Tranexamic Acid API in 2021
4.3 Global Tranexamic Acid API Revenue by Manufacturers
4.3.1 Global Tranexamic Acid API Revenue by Manufacturers (2017-2022)
4.3.2 Global Tranexamic Acid API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Tranexamic Acid API Revenue in 2021
4.4 Global Tranexamic Acid API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Tranexamic Acid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Tranexamic Acid API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Tranexamic Acid API Sales by Purity
5.1.1 Global Tranexamic Acid API Historical Sales by Purity (2017-2022)
5.1.2 Global Tranexamic Acid API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Tranexamic Acid API Sales Market Share by Purity (2017-2028)
5.2 Global Tranexamic Acid API Revenue by Purity
5.2.1 Global Tranexamic Acid API Historical Revenue by Purity (2017-2022)
5.2.2 Global Tranexamic Acid API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
5.3 Global Tranexamic Acid API Price by Purity
5.3.1 Global Tranexamic Acid API Price by Purity (2017-2022)
5.3.2 Global Tranexamic Acid API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Tranexamic Acid API Sales by Application
6.1.1 Global Tranexamic Acid API Historical Sales by Application (2017-2022)
6.1.2 Global Tranexamic Acid API Forecasted Sales by Application (2023-2028)
6.1.3 Global Tranexamic Acid API Sales Market Share by Application (2017-2028)
6.2 Global Tranexamic Acid API Revenue by Application
6.2.1 Global Tranexamic Acid API Historical Revenue by Application (2017-2022)
6.2.2 Global Tranexamic Acid API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Tranexamic Acid API Revenue Market Share by Application (2017-2028)
6.3 Global Tranexamic Acid API Price by Application
6.3.1 Global Tranexamic Acid API Price by Application (2017-2022)
6.3.2 Global Tranexamic Acid API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Tranexamic Acid API Market Size by Purity
7.1.1 North America Tranexamic Acid API Sales by Purity (2017-2028)
7.1.2 North America Tranexamic Acid API Revenue by Purity (2017-2028)
7.2 North America Tranexamic Acid API Market Size by Application
7.2.1 North America Tranexamic Acid API Sales by Application (2017-2028)
7.2.2 North America Tranexamic Acid API Revenue by Application (2017-2028)
7.3 North America Tranexamic Acid API Sales by Country
7.3.1 North America Tranexamic Acid API Sales by Country (2017-2028)
7.3.2 North America Tranexamic Acid API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Tranexamic Acid API Market Size by Purity
8.1.1 Europe Tranexamic Acid API Sales by Purity (2017-2028)
8.1.2 Europe Tranexamic Acid API Revenue by Purity (2017-2028)
8.2 Europe Tranexamic Acid API Market Size by Application
8.2.1 Europe Tranexamic Acid API Sales by Application (2017-2028)
8.2.2 Europe Tranexamic Acid API Revenue by Application (2017-2028)
8.3 Europe Tranexamic Acid API Sales by Country
8.3.1 Europe Tranexamic Acid API Sales by Country (2017-2028)
8.3.2 Europe Tranexamic Acid API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tranexamic Acid API Market Size by Purity
9.1.1 Asia Pacific Tranexamic Acid API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Tranexamic Acid API Revenue by Purity (2017-2028)
9.2 Asia Pacific Tranexamic Acid API Market Size by Application
9.2.1 Asia Pacific Tranexamic Acid API Sales by Application (2017-2028)
9.2.2 Asia Pacific Tranexamic Acid API Revenue by Application (2017-2028)
9.3 Asia Pacific Tranexamic Acid API Sales by Region
9.3.1 Asia Pacific Tranexamic Acid API Sales by Region (2017-2028)
9.3.2 Asia Pacific Tranexamic Acid API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Tranexamic Acid API Market Size by Purity
10.1.1 Latin America Tranexamic Acid API Sales by Purity (2017-2028)
10.1.2 Latin America Tranexamic Acid API Revenue by Purity (2017-2028)
10.2 Latin America Tranexamic Acid API Market Size by Application
10.2.1 Latin America Tranexamic Acid API Sales by Application (2017-2028)
10.2.2 Latin America Tranexamic Acid API Revenue by Application (2017-2028)
10.3 Latin America Tranexamic Acid API Sales by Country
10.3.1 Latin America Tranexamic Acid API Sales by Country (2017-2028)
10.3.2 Latin America Tranexamic Acid API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tranexamic Acid API Market Size by Purity
11.1.1 Middle East and Africa Tranexamic Acid API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Tranexamic Acid API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Tranexamic Acid API Market Size by Application
11.2.1 Middle East and Africa Tranexamic Acid API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Tranexamic Acid API Revenue by Application (2017-2028)
11.3 Middle East and Africa Tranexamic Acid API Sales by Country
11.3.1 Middle East and Africa Tranexamic Acid API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Tranexamic Acid API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hunan Huateng Pharmaceutical
12.1.1 Hunan Huateng Pharmaceutical Corporation Information
12.1.2 Hunan Huateng Pharmaceutical Overview
12.1.3 Hunan Huateng Pharmaceutical Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hunan Huateng Pharmaceutical Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hunan Huateng Pharmaceutical Recent Developments
12.2 Xian Libang Pharmaceutical
12.2.1 Xian Libang Pharmaceutical Corporation Information
12.2.2 Xian Libang Pharmaceutical Overview
12.2.3 Xian Libang Pharmaceutical Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Xian Libang Pharmaceutical Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Xian Libang Pharmaceutical Recent Developments
12.3 Hangzhou Longshine Bio-Tech
12.3.1 Hangzhou Longshine Bio-Tech Corporation Information
12.3.2 Hangzhou Longshine Bio-Tech Overview
12.3.3 Hangzhou Longshine Bio-Tech Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Hangzhou Longshine Bio-Tech Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hangzhou Longshine Bio-Tech Recent Developments
12.4 Inabata France S.A.S
12.4.1 Inabata France S.A.S Corporation Information
12.4.2 Inabata France S.A.S Overview
12.4.3 Inabata France S.A.S Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Inabata France S.A.S Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Inabata France S.A.S Recent Developments
12.5 Transo-Pharm Handels GmbH
12.5.1 Transo-Pharm Handels GmbH Corporation Information
12.5.2 Transo-Pharm Handels GmbH Overview
12.5.3 Transo-Pharm Handels GmbH Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Transo-Pharm Handels GmbH Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Transo-Pharm Handels GmbH Recent Developments
12.6 Malladi Drugs & Pharmaceuticals
12.6.1 Malladi Drugs & Pharmaceuticals Corporation Information
12.6.2 Malladi Drugs & Pharmaceuticals Overview
12.6.3 Malladi Drugs & Pharmaceuticals Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Malladi Drugs & Pharmaceuticals Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Malladi Drugs & Pharmaceuticals Recent Developments
12.7 Rochem International
12.7.1 Rochem International Corporation Information
12.7.2 Rochem International Overview
12.7.3 Rochem International Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Rochem International Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Rochem International Recent Developments
12.8 Metrochem API
12.8.1 Metrochem API Corporation Information
12.8.2 Metrochem API Overview
12.8.3 Metrochem API Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Metrochem API Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Metrochem API Recent Developments
12.9 Ami Lifesciences
12.9.1 Ami Lifesciences Corporation Information
12.9.2 Ami Lifesciences Overview
12.9.3 Ami Lifesciences Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Ami Lifesciences Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Ami Lifesciences Recent Developments
12.10 Supriya Lifescience
12.10.1 Supriya Lifescience Corporation Information
12.10.2 Supriya Lifescience Overview
12.10.3 Supriya Lifescience Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Supriya Lifescience Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Supriya Lifescience Recent Developments
12.11 ALP Pharm
12.11.1 ALP Pharm Corporation Information
12.11.2 ALP Pharm Overview
12.11.3 ALP Pharm Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 ALP Pharm Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 ALP Pharm Recent Developments
12.12 Kyowa Pharma Chemical
12.12.1 Kyowa Pharma Chemical Corporation Information
12.12.2 Kyowa Pharma Chemical Overview
12.12.3 Kyowa Pharma Chemical Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Kyowa Pharma Chemical Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Kyowa Pharma Chemical Recent Developments
12.13 Pfizer Inc
12.13.1 Pfizer Inc Corporation Information
12.13.2 Pfizer Inc Overview
12.13.3 Pfizer Inc Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Pfizer Inc Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Pfizer Inc Recent Developments
12.14 Shilpa Medicare
12.14.1 Shilpa Medicare Corporation Information
12.14.2 Shilpa Medicare Overview
12.14.3 Shilpa Medicare Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Shilpa Medicare Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Shilpa Medicare Recent Developments
12.15 Solara Active Pharma Sciences
12.15.1 Solara Active Pharma Sciences Corporation Information
12.15.2 Solara Active Pharma Sciences Overview
12.15.3 Solara Active Pharma Sciences Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Solara Active Pharma Sciences Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Solara Active Pharma Sciences Recent Developments
12.16 Vitalpharms
12.16.1 Vitalpharms Corporation Information
12.16.2 Vitalpharms Overview
12.16.3 Vitalpharms Tranexamic Acid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Vitalpharms Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Vitalpharms Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Tranexamic Acid API Industry Chain Analysis
13.2 Tranexamic Acid API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Tranexamic Acid API Production Mode & Process
13.4 Tranexamic Acid API Sales and Marketing
13.4.1 Tranexamic Acid API Sales Channels
13.4.2 Tranexamic Acid API Distributors
13.5 Tranexamic Acid API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Tranexamic Acid API Industry Trends
14.2 Tranexamic Acid API Market Drivers
14.3 Tranexamic Acid API Market Challenges
14.4 Tranexamic Acid API Market Restraints
15 Key Finding in The Global Tranexamic Acid API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Tranexamic Acid API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.98
Table 3. Major Manufacturers of 0.99
Table 4. Major Manufacturers of Others
Table 5. Global Tranexamic Acid API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Tranexamic Acid API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 7. Global Tranexamic Acid API Production by Region (2017-2022) & (Tons)
Table 8. Global Tranexamic Acid API Production Market Share by Region (2017-2022)
Table 9. Global Tranexamic Acid API Production by Region (2023-2028) & (Tons)
Table 10. Global Tranexamic Acid API Production Market Share by Region (2023-2028)
Table 11. Global Tranexamic Acid API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Tranexamic Acid API Sales by Region (2017-2022) & (Tons)
Table 13. Global Tranexamic Acid API Sales Market Share by Region (2017-2022)
Table 14. Global Tranexamic Acid API Sales by Region (2023-2028) & (Tons)
Table 15. Global Tranexamic Acid API Sales Market Share by Region (2023-2028)
Table 16. Global Tranexamic Acid API Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Tranexamic Acid API Revenue Market Share by Region (2017-2022)
Table 18. Global Tranexamic Acid API Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Tranexamic Acid API Revenue Market Share by Region (2023-2028)
Table 20. Global Tranexamic Acid API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 21. Global Tranexamic Acid API Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Tranexamic Acid API Sales by Manufacturers (2017-2022) & (Tons)
Table 23. Global Tranexamic Acid API Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Tranexamic Acid API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Tranexamic Acid API Revenue Share by Manufacturers (2017-2022)
Table 26. Tranexamic Acid API Price by Manufacturers 2017-2022 (US$/Kg)
Table 27. Global Tranexamic Acid API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Tranexamic Acid API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tranexamic Acid API as of 2021)
Table 29. Tranexamic Acid API Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Tranexamic Acid API Product Offered
Table 31. Date of Manufacturers Enter into Tranexamic Acid API Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Tranexamic Acid API Sales by Purity (2017-2022) & (Tons)
Table 34. Global Tranexamic Acid API Sales by Purity (2023-2028) & (Tons)
Table 35. Global Tranexamic Acid API Sales Share by Purity (2017-2022)
Table 36. Global Tranexamic Acid API Sales Share by Purity (2023-2028)
Table 37. Global Tranexamic Acid API Revenue by Purity (2017-2022) & (US$ Million)
Table 38. Global Tranexamic Acid API Revenue by Purity (2023-2028) & (US$ Million)
Table 39. Global Tranexamic Acid API Revenue Share by Purity (2017-2022)
Table 40. Global Tranexamic Acid API Revenue Share by Purity (2023-2028)
Table 41. Tranexamic Acid API Price by Purity (2017-2022) & (US$/Kg)
Table 42. Global Tranexamic Acid API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 43. Global Tranexamic Acid API Sales by Application (2017-2022) & (Tons)
Table 44. Global Tranexamic Acid API Sales by Application (2023-2028) & (Tons)
Table 45. Global Tranexamic Acid API Sales Share by Application (2017-2022)
Table 46. Global Tranexamic Acid API Sales Share by Application (2023-2028)
Table 47. Global Tranexamic Acid API Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Tranexamic Acid API Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Tranexamic Acid API Revenue Share by Application (2017-2022)
Table 50. Global Tranexamic Acid API Revenue Share by Application (2023-2028)
Table 51. Tranexamic Acid API Price by Application (2017-2022) & (US$/Kg)
Table 52. Global Tranexamic Acid API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 53. North America Tranexamic Acid API Sales by Purity (2017-2022) & (Tons)
Table 54. North America Tranexamic Acid API Sales by Purity (2023-2028) & (Tons)
Table 55. North America Tranexamic Acid API Revenue by Purity (2017-2022) & (US$ Million)
Table 56. North America Tranexamic Acid API Revenue by Purity (2023-2028) & (US$ Million)
Table 57. North America Tranexamic Acid API Sales by Application (2017-2022) & (Tons)
Table 58. North America Tranexamic Acid API Sales by Application (2023-2028) & (Tons)
Table 59. North America Tranexamic Acid API Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Tranexamic Acid API Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Tranexamic Acid API Sales by Country (2017-2022) & (Tons)
Table 62. North America Tranexamic Acid API Sales by Country (2023-2028) & (Tons)
Table 63. North America Tranexamic Acid API Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Tranexamic Acid API Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Tranexamic Acid API Sales by Purity (2017-2022) & (Tons)
Table 66. Europe Tranexamic Acid API Sales by Purity (2023-2028) & (Tons)
Table 67. Europe Tranexamic Acid API Revenue by Purity (2017-2022) & (US$ Million)
Table 68. Europe Tranexamic Acid API Revenue by Purity (2023-2028) & (US$ Million)
Table 69. Europe Tranexamic Acid API Sales by Application (2017-2022) & (Tons)
Table 70. Europe Tranexamic Acid API Sales by Application (2023-2028) & (Tons)
Table 71. Europe Tranexamic Acid API Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Tranexamic Acid API Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Tranexamic Acid API Sales by Country (2017-2022) & (Tons)
Table 74. Europe Tranexamic Acid API Sales by Country (2023-2028) & (Tons)
Table 75. Europe Tranexamic Acid API Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Tranexamic Acid API Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Tranexamic Acid API Sales by Purity (2017-2022) & (Tons)
Table 78. Asia Pacific Tranexamic Acid API Sales by Purity (2023-2028) & (Tons)
Table 79. Asia Pacific Tranexamic Acid API Revenue by Purity (2017-2022) & (US$ Million)
Table 80. Asia Pacific Tranexamic Acid API Revenue by Purity (2023-2028) & (US$ Million)
Table 81. Asia Pacific Tranexamic Acid API Sales by Application (2017-2022) & (Tons)
Table 82. Asia Pacific Tranexamic Acid API Sales by Application (2023-2028) & (Tons)
Table 83. Asia Pacific Tranexamic Acid API Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Tranexamic Acid API Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Tranexamic Acid API Sales by Region (2017-2022) & (Tons)
Table 86. Asia Pacific Tranexamic Acid API Sales by Region (2023-2028) & (Tons)
Table 87. Asia Pacific Tranexamic Acid API Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Tranexamic Acid API Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Tranexamic Acid API Sales by Purity (2017-2022) & (Tons)
Table 90. Latin America Tranexamic Acid API Sales by Purity (2023-2028) & (Tons)
Table 91. Latin America Tranexamic Acid API Revenue by Purity (2017-2022) & (US$ Million)
Table 92. Latin America Tranexamic Acid API Revenue by Purity (2023-2028) & (US$ Million)
Table 93. Latin America Tranexamic Acid API Sales by Application (2017-2022) & (Tons)
Table 94. Latin America Tranexamic Acid API Sales by Application (2023-2028) & (Tons)
Table 95. Latin America Tranexamic Acid API Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Tranexamic Acid API Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Tranexamic Acid API Sales by Country (2017-2022) & (Tons)
Table 98. Latin America Tranexamic Acid API Sales by Country (2023-2028) & (Tons)
Table 99. Latin America Tranexamic Acid API Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Tranexamic Acid API Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Tranexamic Acid API Sales by Purity (2017-2022) & (Tons)
Table 102. Middle East and Africa Tranexamic Acid API Sales by Purity (2023-2028) & (Tons)
Table 103. Middle East and Africa Tranexamic Acid API Revenue by Purity (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Tranexamic Acid API Revenue by Purity (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Tranexamic Acid API Sales by Application (2017-2022) & (Tons)
Table 106. Middle East and Africa Tranexamic Acid API Sales by Application (2023-2028) & (Tons)
Table 107. Middle East and Africa Tranexamic Acid API Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Tranexamic Acid API Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Tranexamic Acid API Sales by Country (2017-2022) & (Tons)
Table 110. Middle East and Africa Tranexamic Acid API Sales by Country (2023-2028) & (Tons)
Table 111. Middle East and Africa Tranexamic Acid API Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Tranexamic Acid API Revenue by Country (2023-2028) & (US$ Million)
Table 113. Hunan Huateng Pharmaceutical Corporation Information
Table 114. Hunan Huateng Pharmaceutical Description and Major Businesses
Table 115. Hunan Huateng Pharmaceutical Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 116. Hunan Huateng Pharmaceutical Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Hunan Huateng Pharmaceutical Recent Development
Table 118. Xian Libang Pharmaceutical Corporation Information
Table 119. Xian Libang Pharmaceutical Description and Major Businesses
Table 120. Xian Libang Pharmaceutical Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 121. Xian Libang Pharmaceutical Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Xian Libang Pharmaceutical Recent Development
Table 123. Hangzhou Longshine Bio-Tech Corporation Information
Table 124. Hangzhou Longshine Bio-Tech Description and Major Businesses
Table 125. Hangzhou Longshine Bio-Tech Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 126. Hangzhou Longshine Bio-Tech Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Hangzhou Longshine Bio-Tech Recent Development
Table 128. Inabata France S.A.S Corporation Information
Table 129. Inabata France S.A.S Description and Major Businesses
Table 130. Inabata France S.A.S Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 131. Inabata France S.A.S Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Inabata France S.A.S Recent Development
Table 133. Transo-Pharm Handels GmbH Corporation Information
Table 134. Transo-Pharm Handels GmbH Description and Major Businesses
Table 135. Transo-Pharm Handels GmbH Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 136. Transo-Pharm Handels GmbH Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Transo-Pharm Handels GmbH Recent Development
Table 138. Malladi Drugs & Pharmaceuticals Corporation Information
Table 139. Malladi Drugs & Pharmaceuticals Description and Major Businesses
Table 140. Malladi Drugs & Pharmaceuticals Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 141. Malladi Drugs & Pharmaceuticals Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Malladi Drugs & Pharmaceuticals Recent Development
Table 143. Rochem International Corporation Information
Table 144. Rochem International Description and Major Businesses
Table 145. Rochem International Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 146. Rochem International Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Rochem International Recent Development
Table 148. Metrochem API Corporation Information
Table 149. Metrochem API Description and Major Businesses
Table 150. Metrochem API Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 151. Metrochem API Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Metrochem API Recent Development
Table 153. Ami Lifesciences Corporation Information
Table 154. Ami Lifesciences Description and Major Businesses
Table 155. Ami Lifesciences Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 156. Ami Lifesciences Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Ami Lifesciences Recent Development
Table 158. Supriya Lifescience Corporation Information
Table 159. Supriya Lifescience Description and Major Businesses
Table 160. Supriya Lifescience Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 161. Supriya Lifescience Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Supriya Lifescience Recent Development
Table 163. ALP Pharm Corporation Information
Table 164. ALP Pharm Description and Major Businesses
Table 165. ALP Pharm Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 166. ALP Pharm Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. ALP Pharm Recent Development
Table 168. Kyowa Pharma Chemical Corporation Information
Table 169. Kyowa Pharma Chemical Description and Major Businesses
Table 170. Kyowa Pharma Chemical Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 171. Kyowa Pharma Chemical Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Kyowa Pharma Chemical Recent Development
Table 173. Pfizer Inc Corporation Information
Table 174. Pfizer Inc Description and Major Businesses
Table 175. Pfizer Inc Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 176. Pfizer Inc Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Pfizer Inc Recent Development
Table 178. Shilpa Medicare Corporation Information
Table 179. Shilpa Medicare Description and Major Businesses
Table 180. Shilpa Medicare Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 181. Shilpa Medicare Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Shilpa Medicare Recent Development
Table 183. Solara Active Pharma Sciences Corporation Information
Table 184. Solara Active Pharma Sciences Description and Major Businesses
Table 185. Solara Active Pharma Sciences Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 186. Solara Active Pharma Sciences Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Solara Active Pharma Sciences Recent Development
Table 188. Vitalpharms Corporation Information
Table 189. Vitalpharms Description and Major Businesses
Table 190. Vitalpharms Tranexamic Acid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 191. Vitalpharms Tranexamic Acid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Vitalpharms Recent Development
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Tranexamic Acid API Distributors List
Table 196. Tranexamic Acid API Customers List
Table 197. Tranexamic Acid API Market Trends
Table 198. Tranexamic Acid API Market Drivers
Table 199. Tranexamic Acid API Market Challenges
Table 200. Tranexamic Acid API Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Tranexamic Acid API Product Picture
Figure 2. Global Tranexamic Acid API Market Share by Purity in 2021 & 2028
Figure 3. 0.98 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tranexamic Acid API Market Share by Application in 2021 & 2028
Figure 7. Tablets
Figure 8. Capsules
Figure 9. Injection
Figure 10. Others
Figure 11. Tranexamic Acid API Report Years Considered
Figure 12. Global Tranexamic Acid API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 13. Global Tranexamic Acid API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Tranexamic Acid API Production Market Share by Region (2017-2022)
Figure 15. Global Tranexamic Acid API Production Market Share by Region (2023-2028)
Figure 16. Tranexamic Acid API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 17. Tranexamic Acid API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 18. Tranexamic Acid API Production Growth Rate in China (2017-2028) & (Tons)
Figure 19. Tranexamic Acid API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 20. Global Tranexamic Acid API Sales 2017-2028 (Tons)
Figure 21. Global Tranexamic Acid API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Tranexamic Acid API Revenue 2017-2028 (US$ Million)
Figure 23. Global Tranexamic Acid API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Tranexamic Acid API Sales Market Share by Region (2017-2022)
Figure 25. Global Tranexamic Acid API Sales Market Share by Region (2023-2028)
Figure 26. North America Tranexamic Acid API Sales YoY (2017-2028) & (Tons)
Figure 27. North America Tranexamic Acid API Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Europe Tranexamic Acid API Sales YoY (2017-2028) & (Tons)
Figure 29. Europe Tranexamic Acid API Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Tranexamic Acid API Sales YoY (2017-2028) & (Tons)
Figure 31. Asia-Pacific Tranexamic Acid API Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Latin America Tranexamic Acid API Sales YoY (2017-2028) & (Tons)
Figure 33. Latin America Tranexamic Acid API Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Middle East & Africa Tranexamic Acid API Sales YoY (2017-2028) & (Tons)
Figure 35. Middle East & Africa Tranexamic Acid API Revenue YoY (2017-2028) & (US$ Million)
Figure 36. The Tranexamic Acid API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 37. The Top 5 and 10 Largest Manufacturers of Tranexamic Acid API in the World: Market Share by Tranexamic Acid API Revenue in 2021
Figure 38. Tranexamic Acid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 39. Global Tranexamic Acid API Sales Market Share by Purity (2017-2028)
Figure 40. Global Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
Figure 41. Global Tranexamic Acid API Sales Market Share by Application (2017-2028)
Figure 42. Global Tranexamic Acid API Revenue Market Share by Application (2017-2028)
Figure 43. North America Tranexamic Acid API Sales Market Share by Purity (2017-2028)
Figure 44. North America Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
Figure 45. North America Tranexamic Acid API Sales Market Share by Application (2017-2028)
Figure 46. North America Tranexamic Acid API Revenue Market Share by Application (2017-2028)
Figure 47. North America Tranexamic Acid API Sales Share by Country (2017-2028)
Figure 48. North America Tranexamic Acid API Revenue Share by Country (2017-2028)
Figure 49. United States Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 50. Canada Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 51. Europe Tranexamic Acid API Sales Market Share by Purity (2017-2028)
Figure 52. Europe Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
Figure 53. Europe Tranexamic Acid API Sales Market Share by Application (2017-2028)
Figure 54. Europe Tranexamic Acid API Revenue Market Share by Application (2017-2028)
Figure 55. Europe Tranexamic Acid API Sales Share by Country (2017-2028)
Figure 56. Europe Tranexamic Acid API Revenue Share by Country (2017-2028)
Figure 57. Germany Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 58. France Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 59. U.K. Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 60. Italy Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 61. Russia Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 62. Asia Pacific Tranexamic Acid API Sales Market Share by Purity (2017-2028)
Figure 63. Asia Pacific Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
Figure 64. Asia Pacific Tranexamic Acid API Sales Market Share by Application (2017-2028)
Figure 65. Asia Pacific Tranexamic Acid API Revenue Market Share by Application (2017-2028)
Figure 66. Asia Pacific Tranexamic Acid API Sales Share by Region (2017-2028)
Figure 67. Asia Pacific Tranexamic Acid API Revenue Share by Region (2017-2028)
Figure 68. China Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 69. Japan Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 70. South Korea Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 71. India Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 72. Australia Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 73. China Taiwan Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 74. Indonesia Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 75. Thailand Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 76. Malaysia Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Tranexamic Acid API Sales Market Share by Purity (2017-2028)
Figure 78. Latin America Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
Figure 79. Latin America Tranexamic Acid API Sales Market Share by Application (2017-2028)
Figure 80. Latin America Tranexamic Acid API Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Tranexamic Acid API Sales Share by Country (2017-2028)
Figure 82. Latin America Tranexamic Acid API Revenue Share by Country (2017-2028)
Figure 83. Mexico Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Tranexamic Acid API Sales Market Share by Purity (2017-2028)
Figure 87. Middle East and Africa Tranexamic Acid API Revenue Market Share by Purity (2017-2028)
Figure 88. Middle East and Africa Tranexamic Acid API Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Tranexamic Acid API Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Tranexamic Acid API Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Tranexamic Acid API Revenue Share by Country (2017-2028)
Figure 92. Turkey Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Tranexamic Acid API Revenue (2017-2028) & (US$ Million)
Figure 95. Tranexamic Acid API Value Chain
Figure 96. Tranexamic Acid API Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed